Early research (Phase 1)Study completedNCT02890069
What this trial is testing
PDR001 in Combination With LCL161, Everolimus or Panobinostat
Who this might be right for
Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
Novartis Pharmaceuticals 298